Literature DB >> 16516994

BDNF in sensory neurons and chronic pain.

Koichi Obata1, Koichi Noguchi.   

Abstract

Neurotrophic factors, which support neuronal survival and growth during development of the nervous system, have been shown to play significant roles in the transmission of physiologic and pathologic pain. Brain-derived neurotrophic factor (BDNF), synthesized in the primary sensory neurons, is anterogradely transported to the central terminals of the primary afferents in the spinal dorsal horn, where it is involved in the modulation of painful stimuli. In models of inflammatory and neuropathic pain, BDNF synthesis is greatly increased in different populations of dorsal root ganglion (DRG) neurons. Furthermore, it is now known that the activation of mitogen-activated protein kinases occurs in these sensory neurons and contributes to persistent inflammatory and neuropathic pain by regulating BDNF expression. The recent discovery that BDNF upregulation in the DRG and spinal cord contributes to chronic pain hypersensitivity indicates that blocking BDNF in sensory neurons could provide a fruitful strategy for the development of novel analgesics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516994     DOI: 10.1016/j.neures.2006.01.005

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  79 in total

Review 1.  Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain?

Authors:  José García-Cosamalón; Miguel E del Valle; Marta G Calavia; Olivia García-Suárez; Alfonso López-Muñiz; Jesús Otero; José A Vega
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

2.  Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in rats.

Authors:  Y Matsuoka; J Yang
Journal:  Neuroscience       Date:  2012-01-10       Impact factor: 3.590

3.  The fundamental unit of pain is the cell.

Authors:  David B Reichling; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2013-12       Impact factor: 6.961

Review 4.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

5.  Daytime and Nighttime Sleep Characteristics and Pain Among Adults With Stable Heart Failure.

Authors:  Samantha Conley; Shelli L Feder; Sangchoon Jeon; Nancy S Redeker
Journal:  J Cardiovasc Nurs       Date:  2019 Sep/Oct       Impact factor: 2.083

6.  BDNF Overexpression Exhibited Bilateral Effect on Neural Behavior in SCT Mice Associated with AKT Signal Pathway.

Authors:  Mei-Rong Chen; Ping Dai; Shu-Fen Wang; Shu-Hua Song; Hang-Ping Wang; Ya Zhao; Ting-Hua Wang; Jia Liu
Journal:  Neurochem Res       Date:  2016-06-09       Impact factor: 3.996

7.  Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2.

Authors:  Anne Wiemhoefer; Anita Stargardt; Wouter A van der Linden; Maria C Renner; Ronald E van Kesteren; Jan Stap; Marcel A Raspe; Birgitta Tomkinson; Helmut W Kessels; Huib Ovaa; Herman S Overkleeft; Bogdan Florea; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

8.  Neurotrophin signaling and visceral hypersensitivity.

Authors:  Li-Ya Qiao
Journal:  Front Biol (Beijing)       Date:  2014-06

9.  Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.

Authors:  Cherubino Di Lorenzo; Giorgio Di Lorenzo; Grazia Sances; Natascia Ghiotto; Elena Guaschino; Gaetano S Grieco; Filippo M Santorelli; Carlo Casali; Alfonso Troisi; Alberto Siracusano; Francesco Pierelli
Journal:  J Headache Pain       Date:  2009-06-11       Impact factor: 7.277

10.  Elevation of tumor necrosis factor α in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis.

Authors:  F Begum; W Zhu; C Cortes; B MacNeil; M Namaka
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.